share_log

We Think WuXi AppTec (SHSE:603259) Can Stay On Top Of Its Debt

We Think WuXi AppTec (SHSE:603259) Can Stay On Top Of Its Debt

我们认为药明康德(SHSE:603259)能够控制好其债务。
Simply Wall St ·  07/11 23:21

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. Importantly, WuXi AppTec Co., Ltd. (SHSE:603259) does carry debt. But should shareholders be worried about its use of debt?

伯克希尔哈撒韦的查理·芒格支持的外部基金经理李录毫不掩饰地说:“最大的投资风险不是价格波动,而是你是否会遭受永久性资本损失。”当我们考虑公司的风险程度时,我们总是喜欢看它的债务利用情况,因为债务超负荷会导致灭亡。重要的是,药明康德(SHSE: 603259)确实拥有债务。但股东们应该担心它的债务利用吗?

Why Does Debt Bring Risk?

为什么债务会带来风险?

Debt is a tool to help businesses grow, but if a business is incapable of paying off its lenders, then it exists at their mercy. Part and parcel of capitalism is the process of 'creative destruction' where failed businesses are mercilessly liquidated by their bankers. However, a more common (but still painful) scenario is that it has to raise new equity capital at a low price, thus permanently diluting shareholders. Of course, debt can be an important tool in businesses, particularly capital heavy businesses. When we think about a company's use of debt, we first look at cash and debt together.

债务是帮助企业增长的工具,但如果企业无法偿还贷款,那么就存在于贷款人的掌控之下。资本主义的一部分和组成部分是“创造性破坏”过程,失败的企业会被银行家无情地清算。然而,更常见(但仍然痛苦)的情况是,它不得不以低价筹集新的股权资本,从而永久地稀释股东的权益。当然,债务在企业中可能是一个重要的工具,特别是对于资金充沛的企业而言。当考虑一个公司的债务使用时,我们首先看现金和债务。

What Is WuXi AppTec's Net Debt?

药明康德的净债务是多少?

The image below, which you can click on for greater detail, shows that at March 2024 WuXi AppTec had debt of CN¥5.77b, up from CN¥4.65b in one year. However, it does have CN¥16.2b in cash offsetting this, leading to net cash of CN¥10.5b.

下面的图片(点击可查看更详细信息)显示,截至2024年3月,药明康德的债务为57.7亿人民币,比一年前的46.5亿人民币增加。但它也有162亿现金抵消这笔债务,导致净现金为105亿人民币。

big
SHSE:603259 Debt to Equity History July 12th 2024
SHSE:603259负债与权益历史记录2024年7月12日

How Healthy Is WuXi AppTec's Balance Sheet?

药明康德的资产负债表状况如何?

According to the last reported balance sheet, WuXi AppTec had liabilities of CN¥13.4b due within 12 months, and liabilities of CN¥5.50b due beyond 12 months. Offsetting this, it had CN¥16.2b in cash and CN¥8.43b in receivables that were due within 12 months. So it actually has CN¥5.76b more liquid assets than total liabilities.

根据最近公布的资产负债表,药明康德在12个月内有134亿人民币的负债,并有55亿人民币的负债超过12个月。抵消这些负债的是162亿人民币的现金和84.3亿人民币的应收款项,这些应收款项在12个月内到期。因此,它实际上比总负债多57.6亿人民币的流动资产。这种短期流动性意味着药明康德可能很容易偿还其债务,因为它的资产负债表远未过度紧张。简言之,药明康德拥有净现金,因此可以说它没有负担过重的债务!

This short term liquidity is a sign that WuXi AppTec could probably pay off its debt with ease, as its balance sheet is far from stretched. Succinctly put, WuXi AppTec boasts net cash, so it's fair to say it does not have a heavy debt load!

药明康德增加了10%的EBIt,这也是好的。资产负债表显然是分析债务的主要领域。但是,更重要的是未来收益,这将决定药明康德维持健康的资产负债表的能力。因此,如果您想了解专业人士的意见,您可能会发现这份有关分析师盈利预测的免费报告很有趣。最后,一家公司只能用冷硬现金而不是会计利润来偿还债务。药明康德可能在资产负债表上有净现金,但查看它将其利润利息和税前利润(EBIT)转换为自由现金流的能力有多好,因为这将影响其处理负债的需要和能力。

Also good is that WuXi AppTec grew its EBIT at 10% over the last year, further increasing its ability to manage debt. The balance sheet is clearly the area to focus on when you are analysing debt. But it is future earnings, more than anything, that will determine WuXi AppTec's ability to maintain a healthy balance sheet going forward. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.

尽管调查公司的债务水平总是明智的,但在这种情况下,药明康德有105亿人民币的净现金和看起来不错的资产负债表。它还增加了10%的EBIt。因此,我们对药明康德的债务利用没有任何问题。当分析债务水平时,资产负债表是明显的起点。但最终,每个公司都可能存在于资产负债表之外的风险。案例证明:我们发现药明康德有1个警告信号,您需要注意到。

Finally, a company can only pay off debt with cold hard cash, not accounting profits. WuXi AppTec may have net cash on the balance sheet, but it is still interesting to look at how well the business converts its earnings before interest and tax (EBIT) to free cash flow, because that will influence both its need for, and its capacity to manage debt. Looking at the most recent three years, WuXi AppTec recorded free cash flow of 32% of its EBIT, which is weaker than we'd expect. That weak cash conversion makes it more difficult to handle indebtedness.

最后,一家公司只能用冰冷的现金而不是会计利润来偿还债务。药明康德在资产负债表上可能有净现金,但查看最近三年,药明康德记录的自由现金流相当于其EBIt的32%,这比我们预期的要弱。这种弱的现金转换使处理负债更加困难。

Summing Up

总之

While it is always sensible to investigate a company's debt, in this case WuXi AppTec has CN¥10.5b in net cash and a decent-looking balance sheet. And it also grew its EBIT by 10% over the last year. So we don't have any problem with WuXi AppTec's use of debt. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet. Case in point: We've spotted 1 warning sign for WuXi AppTec you should be aware of.

尽管调查公司的债务水平总是明智的,但在这种情况下,药明康德有105亿人民币的净现金和看起来不错的资产负债表。它还增加了10%的EBIt。因此,我们对药明康德的债务利用没有任何问题。当分析债务水平时,资产负债表是明显的起点。但最终,每个公司都可能存在于资产负债表之外的风险。案例证明:我们发现药明康德有1个警告信号,您需要注意到。

If, after all that, you're more interested in a fast growing company with a rock-solid balance sheet, then check out our list of net cash growth stocks without delay.

如果您在所有这些工作之后,更感兴趣于拥有坚实资产负债表的快速发展公司,请立即查看我们的净现金成长股列表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?关注内容?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有反馈? 对内容感到担忧? 请直接与我们联系。 或者,发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发